|
CIT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.80329999999574E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.90250000000103E-05 |
| Normal-vs-Stage2 |
1.507660E-02 |
| Normal-vs-Stage3 |
7.000300E-02 |
| Normal-vs-Stage4 |
3.519800E-03 |
| Stage1-vs-Stage2 |
9.543800E-01 |
| Stage1-vs-Stage3 |
8.566200E-01 |
| Stage1-vs-Stage4 |
6.777600E-01 |
| Stage2-vs-Stage3 |
9.005000E-01 |
| Stage2-vs-Stage4 |
7.829800E-01 |
| Stage3-vs-Stage4 |
9.387400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.415300E-04 |
| Normal-vs-AfricanAmerican |
2.402200E-02 |
| Normal-vs-Asian |
4.155600E-03 |
| Caucasian-vs-AfricanAmerican |
4.327600E-01 |
| Caucasian-vs-Asian |
5.020000E-01 |
| AfricanAmerican-vs-Asian |
8.093200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.561300E-03 |
| Normal-vs-Female |
2.783300E-04 |
| Male-vs-Female |
1.357420E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.597000E-04 |
| Normal-vs-Age(41-60Yrs) |
1.412110E-02 |
| Normal-vs-Age(61-80Yrs) |
1.902920E-03 |
| Normal-vs-Age(81-100Yrs) |
1.339030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.672800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.501600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.999200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.493800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.981800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.933600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.73760000119228E-08 |
| Classical-VS-Follicular |
8.422000E-02 |
| Classical-VS-Other |
8.516200E-01 |
| Classical-VS-Normal |
1.553000E-04 |
| Tall-VS-Follicular |
1.478060E-03 |
| Tall-VS-Other |
4.719600E-03 |
| Tall-VS-Normal |
5.965600E-01 |
| Follicular-VS-Other |
1.071380E-01 |
| Follicular-VS-Normal |
3.138900E-03 |
| Other-VS-Normal |
1.121590E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.404200E-04 |
| Normal-vs-N1 |
1.133860E-02 |
| N0-vs-N1 |
4.072600E-01 |
|
|
